Joshua Heinemann

Ph.D. candidate in Chemistry & Biochemistry

Joshua Heinemann studies metabolism, and is focused on developing technology that will allow researchers to measure changes in metabolism in “real-time” using microfluidics and mass spectrometry. Using this technology living cells are processed and directly measured for changes associated with disease and stress. Development of this technology is important for preemptive treatment or intervention of disease. Microfluidic technology also has the advantages of low cost components and biocompatibility allowing direct integration into a living system. Read more…

 

Shefah Qazi

Ph.D. candidate in Chemistry & Biochemistry

Shefah Qazi works with P22 virus-like particles as next-generation diagnostic tools for medical resonance imaging (MRI) of cardiovascular diseases. Her research focuses on modifying the interior and exterior surfaces of P22 virus-like particles for both encapsulation of small molecule imaging agents and targeted delivery of these agents to diseased tissues. The P22 platform demonstrates a significant increase in contrast over clinically used MRI contrast agents. This research may lead to earlier detection and treatment of cardiovascular related diseases. Read more…